-
公开(公告)号:BR9707394A
公开(公告)日:1999-04-06
申请号:BR9707394
申请日:1997-02-10
Applicant: ABBOTT LAB
Inventor: TASKER ANDREW S , WINN MARTIN , GELDERN THOMAS W VON , SORENSEN BRYAN K , JAE HWAN-SOO , BOYD STEVEN A , HENRY KENNETH J
IPC: A61K31/395 , A61K31/40 , A61K31/4025 , A61K31/675 , A61P1/00 , A61P7/00 , A61P9/00 , A61P11/00 , A61P13/12 , A61P25/04 , A61P35/00 , A61P43/00 , C07D20060101 , C07D207/16 , C07D401/04 , C07D403/04 , C07D405/04 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D419/14 , C07D453/02 , C07F9/572
-
公开(公告)号:CA2297894A1
公开(公告)日:1999-02-11
申请号:CA2297894
申请日:1998-07-27
Applicant: ABBOTT LAB
Inventor: SZCZEPANKIEWICZ BRUCE G , SORENSEN BRYAN K , WINN MARTIN , HENRY KENNETH J , KESTER JEFFREY A , BOYD STEVEN A , HUTCHINS CHARLES W , WITTENBERGER STEVEN J , KING STEVEN A , GELDERN THOMAS W VON , TASKER ANDREW S , JAE HWAN-SOO , LIU GANG
IPC: C07D491/048 , A61K31/40 , A61K31/41 , A61K31/423 , A61K31/435 , A61K31/4355 , A61K31/495 , A61K31/506 , A61K31/535 , A61K31/55 , A61P1/00 , A61P1/04 , A61P7/02 , A61P9/08 , A61P9/10 , A61P9/12 , A61P9/14 , A61P13/08 , A61P13/12 , A61P21/00 , A61P21/04 , A61P25/06 , A61P35/00 , A61P43/00 , C07D207/16 , C07D207/26 , C07D207/27 , C07D403/04 , C07D405/00 , C07D405/04 , C07D405/14 , C07D413/14 , C07D417/14 , C07D491/056
Abstract: A compound of formula (I), or a pharmaceutically acceptable salt thereof, is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
-
公开(公告)号:AU2005201160A1
公开(公告)日:2005-04-14
申请号:AU2005201160
申请日:2005-03-17
Applicant: ABBOTT LAB
Inventor: WINN MARTIN , BOYD STEVEN A , HUTCHINS CHARLES W , JAE HWAN-SOO , TASKER ANDREW S , GELDERN THOMAS W VON , KESTER JEFFREY A , SORENSEN BRYAN K , SZCZEPANKIEWICZ BRUCE G , HENRY KENNETH J , LIU GANG , WITTENBERGER STEVEN J , KING STEVEN A
IPC: C07D405/00
-
公开(公告)号:AU2004205260A1
公开(公告)日:2004-09-23
申请号:AU2004205260
申请日:2004-08-25
Applicant: ABBOTT LAB
Inventor: LIU GANG , LINK JAMES , LYNCH JOHN K , JAE HWAN-SOO , STAEGER MICHAEL A , GUNAWARDANA INDRANI W , FREEMAN JENNIFER C , ZHU GUI-DONG , BOYD STEVEN A , WANG SHELDON , XIN ZHILI , WINN MARTIN , GELDERN THOMAS W VON , PEI ZHONGHUA
IPC: C07D243/08 , A61K20060101 , A61K31/10 , A61K31/165 , A61K31/33 , A61K31/40 , A61K31/4015 , A61K31/41 , A61K31/417 , A61K31/438 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/4468 , A61K31/451 , A61K31/453 , A61K31/454 , A61K31/4545 , A61K31/472 , A61K31/496 , A61K31/4965 , A61K31/506 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K31/541 , A61K31/55 , A61K31/551 , A61P20060101 , A61P29/00 , A61P37/06 , C07C20060101 , C07C323/60 , C07C323/62 , C07D20060101 , C07D205/04 , C07D207/09 , C07D207/12 , C07D207/14 , C07D207/16 , C07D207/26 , C07D207/27 , C07D207/273 , C07D209/08 , C07D209/12 , C07D211/20 , C07D211/22 , C07D211/46 , C07D211/60 , C07D211/62 , C07D211/64 , C07D211/66 , C07D211/70 , C07D213/40 , C07D213/74 , C07D213/81 , C07D215/24 , C07D217/02 , C07D217/04 , C07D217/06 , C07D233/61 , C07D239/42 , C07D241/04 , C07D241/24 , C07D257/04 , C07D279/12 , C07D295/18 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/22 , C07D295/26 , C07D307/24 , C07D307/52 , C07D307/68 , C07D317/58 , C07D317/66 , C07D319/18 , C07D401/04 , C07D401/12 , C07D405/12 , C07D417/12 , C07D471/20 , C07D487/04 , C07D491/113 , C07D521/00
Abstract: The present invention relates to cinnamide compounds of formula (I), in which at least one of R1 to R5 is a "cis-cinnamide" (a) or a "trans-cinnamide" (b) and the other variables are as defined in the claims, that are useful for treating inflammatory and immune diseases, to pharmaceutical compositions containing these compounds and to methods of inhibiting inflammation or suppressing immune response in a mammal.
-
公开(公告)号:AU774564B2
公开(公告)日:2004-07-01
申请号:AU4194400
申请日:2000-04-03
Applicant: ABBOTT LAB
Inventor: LINK JAMES , LIU GANG , PEI ZHONGHUA , GELDERN THOMAS W VON , WINN MARTIN , XIN ZHILI , WANG SHELDON , BOYD STEVEN A , ZHU GUI-DONG , FREEMAN JENNIFER C , GUNAWARDANA INDRANI W , STAEGER MICHAEL A , JAE HWAN-SOO , LYNCH JOHN K
IPC: C07D243/08 , A61K20060101 , A61K31/10 , A61K31/165 , A61K31/33 , A61K31/40 , A61K31/4015 , A61K31/41 , A61K31/417 , A61K31/438 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/4468 , A61K31/451 , A61K31/453 , A61K31/454 , A61K31/4545 , A61K31/472 , A61K31/496 , A61K31/4965 , A61K31/506 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K31/541 , A61K31/55 , A61K31/551 , A61P20060101 , A61P29/00 , A61P37/06 , C07C20060101 , C07C323/60 , C07C323/62 , C07D20060101 , C07D205/04 , C07D207/09 , C07D207/12 , C07D207/14 , C07D207/16 , C07D207/26 , C07D207/27 , C07D207/273 , C07D209/08 , C07D209/12 , C07D211/20 , C07D211/22 , C07D211/46 , C07D211/60 , C07D211/62 , C07D211/64 , C07D211/66 , C07D211/70 , C07D213/40 , C07D213/74 , C07D213/81 , C07D215/24 , C07D217/02 , C07D217/04 , C07D217/06 , C07D233/61 , C07D239/42 , C07D241/04 , C07D241/24 , C07D257/04 , C07D279/12 , C07D295/18 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/22 , C07D295/26 , C07D307/24 , C07D307/52 , C07D307/68 , C07D317/58 , C07D317/66 , C07D319/18 , C07D401/04 , C07D401/12 , C07D405/12 , C07D417/12 , C07D471/20 , C07D487/04 , C07D491/113 , C07D521/00
Abstract: The present invention relates to cinnamide compounds of formula (I), in which at least one of R1 to R5 is a "cis-cinnamide" (a) or a "trans-cinnamide" (b) and the other variables are as defined in the claims, that are useful for treating inflammatory and immune diseases, to pharmaceutical compositions containing these compounds and to methods of inhibiting inflammation or suppressing immune response in a mammal.
-
公开(公告)号:AU2003243622A1
公开(公告)日:2004-01-06
申请号:AU2003243622
申请日:2003-06-17
Applicant: ABBOTT LAB
Inventor: RICHARDS STEVEN J , JACOBSON PEER B , BISHOP RICHARD D , GATES BRADLEY D , GELDERN THOMAS W VON , LINK JAMES T , TU NOAH , KYM PHILIP R , LAI CHUNQIU
IPC: A61K31/575 , A61K31/661 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/46 , A61P9/12 , A61P43/00 , C07J9/00 , C07J41/00 , C07J51/00
Abstract: This invention relates to novel compounds that are liver selective glucocorticoid receptor antagonists, to methods of preparing such compounds, and to methods for using such compounds in the regulation of metabolism, especially lowering serum glucose levels, insulin levels, or lipid levels, and/or decreasing body weight.
-
公开(公告)号:CO5190718A1
公开(公告)日:2002-08-29
申请号:CO98043616
申请日:1998-07-31
Applicant: ABBOTT LAB
Inventor: WINN MARTIN , BOYU STEVEN A , HUTCHINS CHARLES W , HWAN-SOO JEE , TASKER ANDREW S , GELDERN THOMAS W VON , KESTER JEFFREY A , SORENSEN BRYAN K , SZCZEPANKIEW BRUCE G , HENRY KENNETH J , GANG LIU , WITTENBERGER STEVEN J , KING STEVEN A
IPC: A61K31/16 , A61K31/40 , A61K31/435
Abstract: Compuesto de fórmula: en dondeZ es -C(R18)(R19)- ó -C(O)- en donde R18 y R19 son independientemente seleccionados entre hidrógeno y alquil de cadena corta;n es 0 ó 1;R es -(CH2)m-W en donde m es un entero entre 0 - 6 y W es(a) -C(O)2-G en donde G es hidrógeno ó un grupo protector de carboxi,(b) -PO3H2,(c) -P(O)(OH)E en donde E es hidrógeno, alquil de cadena corta ó arilalquil,(d) -CN,(e) -C(O)NHR17 en donde R17 es alquil de cadena corta,(f) alquilaminocarbonil,(g) dialquilaminocarbonil,(h) tetrazolil,(i) hidroxi,(j) alcoxi,(k) sulfonamido,(I) -C(O)NHS(O)2R16 en donde R16 es alquil de cadena corta, haloalquil, aril ó dialquilamino,(m) -S(O)2NHC(O)R16 en donde R16 corresponde a lo previamente definido, - 2 - R1 y R2 se seleccionan independientemente entre hidrógeno, alquil de cadena corta, alquenil, alquinil, alcoxialquil, alcoxicarbonilalquil, hidroxialquil, haloalquil, haloalcoxialquil, alcoxialcoxialquil, tioalcoxialcoxialquil, cicloalquil, cicloalquilalquil, aminocarbonilalquil, alquilaminocarbonil-alquil, dialquilaminocarbonilalquil, aminocarbonilalquenil, alquilaminocarbonilalquenil, dialquilamino-carbonilalquenil, hidroxialquenil, aril, arilalquil,ariloxialquil, arilalcoxialquil, (N-alcanoil-N-alquil)aminoalquil, alquilsulfonilamidoalquil, heterocíclico, (heterocíclico)alquil y (Raa)(Rbb)N-Rcc- en donde Raa es aril ó arilalquil, Rbb es hidrógeno ó alcanoil y Rcc es alquilen, con la condición de que uno ó ambos sustituyentes R1 y R2 sean diferentes a hidrógeno;R3 es(a) R4-C(O)-R5-, R4-R5a-, R4-C(O)-R5-N(R6)-, R6-S(O)2-R7- Ó R26-S(O)2-R27-en donde R5 es (i) un enlace covalente, (ii) alquilen, (iii) alquenilen, (iv) -N(R20)-R8- ó -R8a-N(R20)-R8-en donde R8 y R8a se seleccionan independientemente del grupo conformado por alquilen y alquenilen y R20 es hidrógeno, alquil de cadena corta, alquenil, haloalquil, alcoxialquil, haloalcoxialquil, cicloalquil ó cicloalquilalquil ó (v) -O-R9- ó -R9a-O-R9- en donde R9 y R9a se seleccionanindependientemente entre alquilenos;R5a es (i) alquilen ó (ii) alquenilen;R7 es (i) un enlace covalente, (ii) alquilen, (iii) alquenilen ó(iv) -N(R21)-R10- ó -R10a-N(R21)-R10-en donde R10 y R10a se seleccionan independientemente del grupo conformado por alquilen y alquenilen yR21 es hidrógeno, alquil de cadena corta, alquenil, haloalquil, alcoxialquil, haloalcoxialquil, aril ó arilalquil;R4 y R6 son independientemente seleccionados de un grupo conformado por:(i) (R11)(R12)N- en donde R11 y R12 se seleccionan independientemente del grupo conformado por(1) hidrógeno,(2) alquil de cadena corta,(3) haloalquil,(4) alcoxialquil,(5) haloalcoxialquil,(6) alquenil,(7) alquinil,(8) cicloalquil,(9) cicloalquilalquil,(10) aril,(11) heterocíclico,(12) arilalquil,(13) (heterocíclico)alquil,(14) hidroxialquil,(15) alcoxi,(16) aminoalquil,{17) trialquilaminoalquil,(18) alquilaminoalquil,(19) dialquilaminoalquil, y(20) carboxialquil,- 3 -(ii) alquil de cadena corta,(iii) alquenil,(iv) alquinil,(v) cicloalquil,(vi) cicloalquilalquil,(vii) aril,(viii) arilalquil,(ix) heterocíclico,(x) (heterocíclico)alquil,(xi) alcoxialquil,(xii) hidroxialquil,(xiii) haloalquil,(xiv) haloalquenil,(xv) haloalcoxialquil,(xvi) haloalcoxi,(xvii) alcoxihaloalquil,(xviii) alquilaminoalquil,(xix) dialquilaminoalquil(xx) alcoxi, y (xxi)en donde z va de 0 a 5 y R7a es alquilen;R26 es (i) alquil de cadena corta, (ii) haloalquil, (iii) alquenil, (iv) alquinil, (v) cicloalquil, (vi) cicloalquilalquil, (vii) aril, (viii) arilalquil, (ix) heterocíclico (x) (heterocíclico)alquil, (xi) (aIcoxialquil, ó (xii) haloalquil sustituido con alcoxi, yR27 es alquilen o alquenilen;(b) R22-O-C(O)-R23;- en donde R22 es un grupo protector de carboxi ó un heterocíclico y R23 es (i) un enlace covalente, (ii) alquilen, (iii) alquenilen ó (iv) -N(R24)-R25- en donde R25 es alquilen y R24 es hidrógeno ó alquil de cadena corta,(c) alquil de cadena corta,(d) alquenil,(e) alquinil,(f) cicloalquil,(9) cicloalquilalquil,(h) aril,(i) arilalquil,(j) ariloxialquil,(k) heterocíclico,(I) (heterocíclico)alquil,(m) alcoxialquil,(n) alcoxialcoxialquil, ú(o) R13-C(O)-CH(R14)-en donde R13 es amino, alquilamino ó dialquilamino, y R14 es aril, R15-C(O)- en donde R15 es amino, alquilamino ó dialquilamino;ó una sal farmacéuticamente aceptable de éste.
-
28.
公开(公告)号:AU2984101A
公开(公告)日:2002-08-08
申请号:AU2984101
申请日:2001-03-23
Applicant: ABBOTT LAB
Inventor: WINN MARTIN , KING STEVEN A , WITTENBERGER STEVEN J , LIU GANG , HENRY KENNETH J JR , SZCZEPANKIEWICZ BRUCE G , SORENSEN BRYAN K , KESTER JEFFREY A , GELDERN THOMAS W VON , TASKER ANDREW , JAE HWAN-SOO , HUTCHINS CHARLES W , BOYD STEVEN A
IPC: A61K31/40 , C07D207/16 , C07D401/04 , C07D405/04 , C07D405/14 , C07F9/572 , C07F9/59
-
公开(公告)号:TR200000993T2
公开(公告)日:2000-12-21
申请号:TR200000993
申请日:1998-07-27
Applicant: ABBOTT LAB
Inventor: WINN MARTIN , BOYD STEVEN A , HUTCHINS CHARLES W , JAE HWAN-SOO , TASKER ANDREW S , GELDERN THOMAS W VON , KESTER JEFFREY A , SORENSEN BRYAN K , SZCZEPANKIEWICZ BRUCE G , HENRY KENNETH J , LIU GANG , WITTENBERGER STEVEN J , KING STEVEN A
IPC: C07D491/048 , A61K31/40 , A61K31/41 , A61K31/423 , A61K31/435 , A61K31/4355 , A61K31/495 , A61K31/506 , A61K31/535 , A61K31/55 , A61P1/00 , A61P1/04 , A61P7/02 , A61P9/08 , A61P9/10 , A61P9/12 , A61P9/14 , A61P13/08 , A61P13/12 , A61P21/00 , A61P21/04 , A61P25/06 , A61P35/00 , A61P43/00 , C07D207/16 , C07D207/26 , C07D207/27 , C07D403/04 , C07D405/00 , C07D405/04 , C07D405/14 , C07D413/14 , C07D417/14 , C07D491/056
-
公开(公告)号:BR9810031A
公开(公告)日:2000-09-12
申请号:BR9810031
申请日:1998-06-08
Applicant: ABBOTT LAB
Inventor: TASKER ANDREW S , WINN MARTIN , BOYD STEVEN A , JAE HWAN-SOO , GELDERN THOMAS W VON , SORENSEN BRYAN K , HENRY KENNETH J
IPC: A61K31/40 , C07D20060101 , C07D207/16 , C07D405/04
Abstract: A compound of formula (I), or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
-
-
-
-
-
-
-
-
-